Company: SNWV
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001628280-25-038937
Chunk: 35

Company: SANUWAVE Health, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 1
Chunk 35
---
Net Income (Loss)$1,055 $6,561 $(4,621)$2,033 Other Comprehensive Income (Loss)Foreign currency translation adjustments- 10 - 121 Total Comprehensive Income (Loss)$1,055 $6,571 $(4,621)$2,154 Earnings (Loss) per Share:Basic *$0.12 $2.08 $(0.54)$0.65 Diluted *$0.01 $1.77 $(0.54)$0.55 Weighted average shares outstandingBasic *8,561,7373,152,5958,554,7063,126,000Diluted *9,167,8463,699,5018,554,7063,663,730

* Reflects a one-for-three hundred seventy-five (1:375) reverse stock split of the outstanding shares of the Company's common stock effected on October 18, 2024.

The accompanying notes to condensed consolidated financial statements are an integral part of these financial statements.

5

Table of Contents

SANUWAVE HEALTH, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

(UNAUDITED)

(In thousands, except share data)

Three Months Ended June 30, 2025Common StockNumber ofSharesIssued andOutstandingPar ValueAdditional Paid-in CapitalAccumulated Deficit Accumulated Other Comprehensive IncomeTotal Balances as of March 31, 20258,548,473$9 $239,786 $(257,097)$10 $(17,292)Stock-based compensation-- 1,132 - - 1,132 Stock options exercised17,008- 253 - - 253 Shares granted in lieu of board of director fees2,524- 77 - - 77 Foreign currency translation adjustment-- - - - - Net income-- - 1,055 - 1,055 Balances as of June 30, 20258,568,005$9 $241,248 $(256,042)$10 $(14,775)

Three Months Ended June 30, 2024Common StockNumber ofSharesIssued andOutstandingPar ValueAdditional Paid-in CapitalAccumulated DeficitAccumulated Other Comprehensive IncomeTotalBalances as of March 31